Skip to main content Skip to main navigation menu Skip to site footer

Age and Gender as The Risk Factors for Mortality Rate in COVID-19 Patients



Abstract

Background: Coronavirus disease-19 is a disease caused by the SARS-CoV-2 virus. This virus is the newest type of coronavirus identified in humans. A recent study in 2022 in several different age groups found that older age, men, comorbidities such as hypertension, diabetes, and malignancy, were independent risk factors for mortality in COVID-19 inpatients. This study aimed to determine the risk factors for age and gender in the COVID-19 mortality rate.

Method: The design study was a retrospective case control. The research subjects were 6,697 patients from the secondary data medical record from March 2020 to September 2021 at Pasar Minggu Regional General Hospital.

Results: Results obtained 3313 men (49.5%) and 3384 women (50.5%). Men patients have a 1.5 times greater risk of mortality rate [OR 1.5 (1.3-1. 7)] compared to women. Elderly patients have a 3 times greater mortality risk than non-elderly people [OR 3.1 (2.6-3.7)]. There was a correlation between the after-treatment condition and age (p = 0.05).

Conclusion: This study concludes that the elderly and men are the risk factors for the mortality rate in COVID-19 patients at Pasar Minggu Regional General Hospital.

Keywords: Age Gender Covid-19 Patients Mortality

References

  1. Health IM of. COVID-19 Situation Bulletin [Internet]. 2020. Available from: https://pusdatin.kemkes.go.id/download.php?file=download/pusdatin/buletin/buletin-Situasi-COVID-19_opt.pdf
  2. WHO. WHO Coronavirus (COVID-19) Dashboard [Internet]. 2022. Available from: https://covid19.who.int/
  3. Malik J, Ahmed S, Al E. The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It. Saudi J Biol Sci. 2022;29(5):3586–99.
  4. Zhang H, Wu Y, et al. Age-Related Risk Factors and Complications of Patients With COVID-19: A Population-Based Retrospective Study. Front Med. 2022;8:757459.
  5. Singhal S, Kumar P, Singh S, Saha S, Dey AB. Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis. BMC Geriatr. 2021;21(1):1-9.
  6. Z W, Qiang W, Ke H. A Handbook of 2019-nCoV Pneumonia Control and Prevention. Hubei SciTechnol Press. 2020;1–108.
  7. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. In JAMA - Journal of the American Medical Association (Vol. 324. JAMA - J Am Med Assoc. 2020;324(8):782-793.
  8. Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgraduate Medical Journal. 2021;97(1147):312-320.
  9. CDC. COVID-19 Virus [Internet]. 2020. Available from: https://www.cdc.gov/media/subtopic/images.htm
  10. Amber L. Mueller, Maeve S.McNamara, David A. Sinclair. Why does COVID-19 disproportionately affect older people? Aging (Albany NY). 2020;12(10):9959.
  11. Al-Zahrani J. SARS-CoV-2 associated COVID-19 in the geriatric population: A brief narrative review. Saudi J Biol Sci. 2021;28:738–743.
  12. Covid-19 ITF. Distribution Map (internet) [Internet]. Available from: https://covid19.go.id/petasebaran
  13. Karyono DR, Wicaksana AL. Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. J Community Empower Heal. 2020;3(2):77.
  14. Baihaqi F, et al. Faktor-Faktor yang Berhubungan dengan Lama Rawat Inap Pasien COVID-19 di RSUD Serui Provinsi Papua:Studi Potong Lintang. J Penyakit Dalam Indones. 2021;8(4):187–94.
  15. Moran K, et al. A Meta-Analysis of the Association between Gender and Protective Behaviors in Response to Respiratory Epidemics and Pandemics. PLoS One. 2016;11(10):e0164541.
  16. Griffith D, et al. Men and COVID-19: A Biopsychosocial Approach to Understanding Sex Differences in Mortality and Recommendations for Practice and Policy Interventions. CDC [Internet]. 2020;17(E63). Available from: www.cdc.gov/pcd/issues/2020/20_0247.htm
  17. Pachchhapurkar PM. Proposed estrogen therapy for covid 19 and other microbial infections. INDIAN J Appl Res. 2020;10(9):13-15.
  18. Kuehn B. COVID-19 in Clinicians—More Cases in Women, More Deaths in Men. JAMA - J Am Med Assoc. 2021;325(15):1498.
  19. Doerre A, Doblhammer G. The influence of gender on COVID-19 infections and mortality in Germany: Insights from age and gender-specific modeling of contact rates, infections, and deaths in the early phase of the pandemic. PLoS One. 2022;17(5):e0268119.
  20. Bambra C, et al. COVID-19 and the gender health paradox. Scand J Public Health. 2021;49:17–26.
  21. Jin J, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality [Internet]. 2020:152. Available from: https://www.frontiersin.org/articles/10.3389/fpubh.2020.00152/full

How to Cite

Rachmawati, M. R., Amiarno, Y., Restuti, Y., Guslianti, W., Adriyanti, L., & Fajriah, N. (2022). Age and Gender as The Risk Factors for Mortality Rate in COVID-19 Patients. Bali Medical Journal, 11(3), 2017–2021. https://doi.org/10.15562/bmj.v11i3.3446
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
0

Share

Search Panel

Maria Regina Rachmawati
Google Scholar
Pubmed
BMJ Journal

Yudi Amiarno
Google Scholar
Pubmed
BMJ Journal

Yeni Restuti
Google Scholar
Pubmed
BMJ Journal

Wida Guslianti
Google Scholar
Pubmed
BMJ Journal

Luzi Adriyanti
Google Scholar
Pubmed
BMJ Journal

Nurul Fajriah
Google Scholar
Pubmed
BMJ Journal